Blog
RSS FeedPosted by Michael Wonder on 08 Feb 2021
TGA one of only five non-European regulators invited to participate on European committees on COVID-19 vaccines and therapeutics
8 February 2021 - Australia, through the TGA, is one of only five non-European Union regulators formally invited to participate ...
Posted by Michael Wonder on 07 Feb 2021
Patient and public involvement in health technology assessment: update of a systematic review of international experiences
5 February 2021 - This paper summarises the current evidence on patient and public involvement in health technology assessment in order ...
Posted by Michael Wonder on 31 Jan 2021
Evaluation of the impact of patient input in health technology assessments at NICE
29 January 2021 - Accounts of patient experiences are increasingly used in health technology assessment processes. However, we know little about ...
Posted by Michael Wonder on 24 Jan 2021
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health
22 January 2021 - In recognition of patients’ roles using, and contributing to, a publicly funded health system, the Canadian Agency ...
Posted by Michael Wonder on 20 Jan 2021
Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment
20 January 2021 - Patient involvement in the process of producing health technology assessments has become increasingly important. In the ...
Posted by Michael Wonder on 20 Jan 2021
Scottish Health Technologies Group: enhancing patient engagement
20 January 2021 - The Scottish Health Technologies Group provides evidence support and advice to the National Health Service in Scotland ...
Posted by Michael Wonder on 04 Dec 2020
Access Consortium statement on COVID-19 vaccines evidence
4 December 2020 - The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the ...
Posted by Michael Wonder on 27 Oct 2020
Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA
21 October 2020 - The history of European health technology assessment goes back more than 30 years. Almost as old as ...
Posted by Michael Wonder on 18 Oct 2020
Community engagement in health technology assessment and beyond: from guests in the process to hosts
15 October 2020 - In health technology assessment, clinical and economic evidence are assessed in the regulatory and reimbursement environments, with ...
Posted by Michael Wonder on 10 Oct 2020
In landmark international program, HTA agencies around the world access ICER's customisable COVID-19 cost-effectiveness model
9 October 2020 - Leveraging ICER’s new cloud-based Interactive Modeler platform, Quebec’s HTA agency has used the COVID-19 model to inform ...
Posted by Michael Wonder on 09 Oct 2020
MHRA to join Project Orbis
8 October 2020 - The UK is set to join the US FDA's Project Orbis at the start of next ...
Posted by Michael Wonder on 05 Oct 2020
Physician–patient shared decision making, patient satisfaction, and adoption of new health technology in China
2 October 2020 - A cross-sectional study was conducted from July 2016 to October 2016 in Fujian Province and Shanghai, in ...
Posted by Michael Wonder on 29 Sep 2020
Australian patients to benefit from ongoing collaboration between peak medicine bodies
29 September 2020 - ACCC extends conditional authorisation to Medicines Australia and the Generic and Biosimilar Medicines Association ...
Posted by Michael Wonder on 03 Sep 2020
CMS care compare empowers patients when making important health care decisions
3 September 2020 - Today, under the leadership of President Trump, the Centers for Medicare & Medicaid Services launched Care Compare, ...
Posted by Michael Wonder on 18 Aug 2020
Coronavirus updates: WHO calls for global co-operation and an end to 'vaccine nationalism'
19 August 2020 - The World Health Organization's chief says governments and drug-makers are putting their own interests ahead of ...